In this study, the role of LRRK2 as a novel potential regulator in the pathogenesis of SLE was suggested based on the correlation of abnormal LRRK2 expression in B cells with disease severity of SLE, and further validated in a pristane-induced lupus-prone model. Here, LRRK2 is linked to systemic lupus erythematosus.